Standing Alone against Placebo

Within the United States, entry-level basic courses are commonly named 101.  

Another area where one can be sure that no drug is used alone is in the treatment of pain, where our best drugs give only partial relief, and so drugs must be combined. In addition, many pain states have inflammatory components so that anti-inflammatory drugs are almost always included in the menu, and interaction of a new pain medicine with anti-inflammatories is not permissible. 

Pozicor, a novel highly effective antihypertensive drug, had interaction with the cholesterollowering statins and had to be withdrawn. 

Even with all the developments of molecular biology and molecular genetics, one should not forget the significant information that can be gleaned from good doctoring. Sick people come to the doctor and tell 

Chapter 17 / Linking Putative Irgets to Disease States 

---

A Phase II study was recently completed whereby Org-25935 was compared against placebo for the ability to improve negative symptoms in 246 subjects maintained on a stable dose of an atypical antipsychotic (data not disclosed) [46]. A second Phase II study in progress (200 patients) is designed to assess the efficacy of Org-25935 as a stand-alone therapy versus placebo, using olanzapine as the active control [46]. Org-25935 is also being investigated in separate Phase II studies as a treatment for panic disorder and for recidivism in subjects with alcohol dependence [46]. 

---